Webcast for Investors, Analysts and Media, 7:00pm-8:00pm JST (Presentation and Q&A Session)
|Quarterly Financial Report|
|Presentation (for Investors)|
|Underlying Core Reconciliation|
|Clinical Trial Summary||—||—||—|
|Financial Statements (Tokyo Stock Exchange filing)|
|Annual Securities Report/
Quarterly Securities Report *
|Form 20-F (SEC filing)**||—||—||—|
#1: Conference call (Call 1: Presentation and Q&A Session)
#2: U.S. timezone call (Call 2: Q&A Session only)
* The English version of the Annual Securities Report/Quarterly Securities Report is provided as a reference material to assist foreign inventors in understanding the Securities Report, which was filed with Japanese FSA (Financial Services Agency). We do not provide assurance about the accuracy, validity, or coverage of the English translation of this document, and if the description and explanation of this document differs from those of the Japanese Annual Securities Report/Quarterly Securities Report which was filed, the Securities Report in Japanese shall prevail.
**Takeda will provide a hard copy of its latest Annual Report on Form 20-F, which includes its most recent complete audited financial statements, free of charge to any securityholder upon request. To request a hard copy, securityholders should contact Takeda Investor Relations at email@example.com with their name, address, and telephone number.